Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly

被引:24
作者
Govoni, S
Racchi, M
Masoero, E
Zamboni, M
Ferini-Strambi, L
机构
[1] Univ Pavia, Dept Expt & Appl Pharmacol, Pavia, Italy
[2] San Raffaele Sci Inst, Dept Neurol, I-20132 Milan, Italy
关键词
elderly; depression; movement disorders; Parkinson's disease; antidepressant drugs; extrapyramidal symptoms;
D O I
10.1038/sj.mp.4000801
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Depression is the most prevalent functional psychiatric disorder in late rife. The problem of motor disorders associated with antidepressant use is relevant in the elderly. Elderly people are physically more frail and more likely to be suffering from physical illness, and any drug given may exacerbate pre-existing diseases, or interact with other drug treatments being administered for physical conditions. Antidepressants have been reported to induce extrapyramidal symptoms, including parkinsonism. These observations prompted us to review the neurobiological mechanism that may be involved in this complex interplay including neurotransmitters and neuronal circuits involved in movement and emotion control and their changes related to aging and disease. The study of the correlations between motor and mood disorders and their putative biochemical bases, as presented in this review, provide a rationale either to understand or to foresee motor side effects for psychotropic drugs, in particular antidepressants.
引用
收藏
页码:134 / 142
页数:9
相关论文
共 70 条
  • [1] Banki C M, 1986, Ann N Y Acad Sci, V487, P221, DOI 10.1111/j.1749-6632.1986.tb27901.x
  • [2] Sensitivity to ageing of the limbic dopaminergic system: a review
    Barili, P
    De Carolis, G
    Zaccheo, D
    Amenta, F
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 1998, 106 (1-2) : 57 - 92
  • [3] BARUCHA KJ, 1996, MOVEMENT DISORD, V3, P324
  • [4] Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography
    Becker, T
    Becker, G
    Seufert, J
    Hofmann, E
    Lange, KW
    Naumann, M
    Lindner, A
    Reichmann, H
    Riederer, P
    Beckmann, H
    Reiners, K
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (05) : 590 - 596
  • [5] Depression in Parkinson's disease:: brainstem midline alteration on transcranial sonography and magnetic resonance imaging
    Berg, D
    Supprian, T
    Hofmann, E
    Zeiler, B
    Jäger, A
    Lange, KW
    Reiners, K
    Becker, T
    Becker, G
    [J]. JOURNAL OF NEUROLOGY, 1999, 246 (12) : 1186 - 1193
  • [6] Amisulpride versus amineptine and placebo for the treatment of dysthymia
    Boyer, P
    Lecrubier, Y
    Stalla-Bourdillon, A
    Fleurot, O
    [J]. NEUROPSYCHOBIOLOGY, 1999, 39 (01) : 25 - 32
  • [7] DOPAMINE AND DEPRESSION
    BROWN, AS
    GERSHON, S
    [J]. JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 91 (2-3) : 75 - 109
  • [8] Metabolism of the newer antidepressants - An overview of the pharmacological and pharmacokinetic implications
    Caccia, S
    [J]. CLINICAL PHARMACOKINETICS, 1998, 34 (04) : 281 - 302
  • [9] CASEY DE, 1990, WESTERN J MED, V153, P535
  • [10] CLAYTON AH, 1995, PSYCHOPHARMACOL BULL, V31, P259